Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.
The FDA is warning that these drugs used to treat advanced breast cancers may cause rare but severe inflammation of the lungs.
FDA approves immunotherapy plus targeted therapy combo for initial treatment of advanced renal cell carcinoma.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Immunotherapy and targeted therapy combo is now approved for first-time treatment of advanced renal cell carcinoma.
Ibrance appears safe and effective for men in real-world use.
The decision to sign up for a clinical trial is not easy; there are risks for everything we do in terms of health and wellness.
Stop me if you’ve heard this one before.
First-line immunotherapy combo delayed disease progression and reduced the risk of death by nearly half.
Bavencio or Keytruda plus targeted therapy slowed disease progression in Phase III studies.
I am happy to be doing my small part in helping test a new class of drug for breast cancer patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.